Blood Pressure Medications Recalled Contain Unacceptable Level of Cancer-Causing IngredientBy Radiant Health
Published: October 24, 2021
Health News Briefs
Two blood pressure drugs, irbesartan tablets and irbesartan and hydrochlorothiazide tablets, are being recalled because they contain higher than acceptable levels of the cancer-causing substance, N-nitrosoirbesartan. Lupin Pharmaceuticals issued the recall voluntarily. So far, only four people have reported illness potentially related to the medicine. The first batches of the affected medicine were distributed in October of 2018. Lupin Pharmaceuticals has been contacting pharmacies, supermarkets, and wholesalers to initiate a return of their recalled products. The company says that anyone who is currently taking the medication should contact their doctor for advice on next steps.
Like what you're reading? Sign up for our free newsletter and never miss a post! Plus get a FREE digital version of our Issue No.10 with sign up.
- Kool-Aid And Other Sweet Drinks Recalled for Glass and Metal Pieces - November 28, 2021
- Covid-19 Cases in Children Spike Dramatically - November 28, 2021
- Omicron, A New Coronavirus Variant, Fuels Concerns Worldwide - November 28, 2021
- Major Pharmacies in Ohio to Pay for Opioid Crisis - November 28, 2021
- White Chocolate Bark with Okra, Raspberries, and Papaya - November 21, 2021
- The FDA Expands Covid-19 Vaccine Booster Dose for All Adults - November 21, 2021
- U.S. Drug Overdoses Rose Sharply Last Year - November 21, 2021
- Epidemiologists Warn of Covid-19 Winter Surge - November 21, 2021
- Pfizer’s Antiviral Pill Will Be Sold to Dozens of Poor Nations at a Discount - November 21, 2021
- Breathwork: How To Reduce Stress With Breathing Exercises - November 13, 2021